Robert M. Petitt

1.2k total citations
20 papers, 850 citations indexed

About

Robert M. Petitt is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Robert M. Petitt has authored 20 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 12 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in Robert M. Petitt's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (5 papers) and Platelet Disorders and Treatments (5 papers). Robert M. Petitt is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (5 papers) and Platelet Disorders and Treatments (5 papers). Robert M. Petitt collaborates with scholars based in United States. Robert M. Petitt's co-authors include Murray N. Silverstein, Lawrence A. Solberg, Ayalew Tefferi, David L. Graham, Gordon W. Dewald, José L. Díez‐Martín, Lee Schacter, John Fleming, H. Clark Hoagland and Patricia J.M. Best and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and American Journal of Clinical Nutrition.

In The Last Decade

Robert M. Petitt

19 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert M. Petitt United States 14 582 564 292 163 113 20 850
Kip R. Hartman United States 10 420 0.7× 527 0.9× 49 0.2× 85 0.5× 71 0.6× 15 748
Junji Tomiyama Japan 13 100 0.2× 235 0.4× 110 0.4× 37 0.2× 153 1.4× 47 565
C. H. W. Leeksma Netherlands 14 188 0.3× 463 0.8× 148 0.5× 22 0.1× 47 0.4× 17 697
R Goudsmit Netherlands 15 268 0.5× 475 0.8× 78 0.3× 29 0.2× 66 0.6× 43 736
Sonja Skoupy Austria 10 75 0.1× 141 0.3× 88 0.3× 95 0.6× 82 0.7× 12 368
C. Garner United Kingdom 8 525 0.9× 459 0.8× 204 0.7× 30 0.2× 45 0.4× 15 821
Raïfah Makdassi France 9 108 0.2× 174 0.3× 260 0.9× 28 0.2× 237 2.1× 10 679
Y. Ravindranath United States 14 83 0.1× 266 0.5× 183 0.6× 51 0.3× 43 0.4× 25 625
Z Rolović Serbia 12 162 0.3× 290 0.5× 60 0.2× 23 0.1× 46 0.4× 53 447
Éstelle Desport France 12 91 0.2× 122 0.2× 375 1.3× 39 0.2× 67 0.6× 38 610

Countries citing papers authored by Robert M. Petitt

Since Specialization
Citations

This map shows the geographic impact of Robert M. Petitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Petitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Petitt more than expected).

Fields of papers citing papers by Robert M. Petitt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Petitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Petitt. The network helps show where Robert M. Petitt may publish in the future.

Co-authorship network of co-authors of Robert M. Petitt

This figure shows the co-authorship network connecting the top 25 collaborators of Robert M. Petitt. A scholar is included among the top collaborators of Robert M. Petitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert M. Petitt. Robert M. Petitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fruchtman, Steven, Robert M. Petitt, Harriet S. Gilbert, G I Fiddler, & A. G. Lyne. (2005). Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders. Leukemia Research. 29(5). 481–491. 65 indexed citations
2.
Petitt, Robert M.. (1998). Precipitous Fall in Platelet Count with Anagrelide: Case Report and Critique of Dosing Recommendations—A Comment. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(3). 659–659. 2 indexed citations
3.
Best, Patricia J.M. & Robert M. Petitt. (1998). Multiple Skin Cancers Associated With Hydroxyurea Therapy. Mayo Clinic Proceedings. 73(10). 961–963. 31 indexed citations
4.
Solberg, Lawrence A., Ayalew Tefferi, Jerzy S. Tarach, et al.. (1997). The effects of anagrelide on human megakaryocytopoiesis. British Journal of Haematology. 99(1). 174–180. 62 indexed citations
5.
Tefferi, Ayalew, Murray N. Silverstein, Robert M. Petitt, Ruben A. Mesa, & Lawrence A. Solberg. (1997). Anagrelide as a New Platelet-Lowering Agent in Essential Thrombocythemia: Mechanism of Action, Efficacy, Toxicity, Current Indications. Seminars in Thrombosis and Hemostasis. 23(4). 379–383. 59 indexed citations
6.
Fairbanks, Virgil F., George G. Klee, Gregory A. Wiseman, et al.. (1996). Measurement of Blood Volume and Red Cell Mass: Re-examination of 51Cr and 125I Methods. Blood Cells Molecules and Diseases. 22(2). 169–186. 77 indexed citations
7.
Petitt, Robert M.. (1995). Polycythemia Vera and the Myeloproliferative Disorders. Mayo Clinic Proceedings. 70(9). 919–919. 34 indexed citations
8.
Petitt, Robert M.. (1995). Polycythemia Vera and the Myeloproliferative Disorders. Mayo Clinic Proceedings. 70(9). 919–919. 46 indexed citations
9.
Kay, Andrea, Lawrence A. Solberg, Douglas A. Nichols, & Robert M. Petitt. (1991). Prognostic Significance of Computed Tomography of the Brain in Thrombotic Thrombocytopenic Purpura. Mayo Clinic Proceedings. 66(6). 602–607. 17 indexed citations
10.
Díez‐Martín, José L., David L. Graham, Robert M. Petitt, & Gordon W. Dewald. (1991). Chromosome Studies in 104 Patients With Polycythemia Vera. Mayo Clinic Proceedings. 66(3). 287–299. 108 indexed citations
11.
Hoagland, H. Clark, et al.. (1991). Essential Thrombocythemia in Young Adults. Mayo Clinic Proceedings. 66(2). 149–154. 69 indexed citations
12.
Tefferi, Ayalew, et al.. (1989). Adult‐onset cyclic bicytopenia: A case report and review of treatment of cyclic hematopoiesis. American Journal of Hematology. 30(3). 181–185. 13 indexed citations
13.
Silverstein, Murray N., et al.. (1988). Anagrelide: A New Drug for Treating Thrombocytosis. New England Journal of Medicine. 318(20). 1292–1294. 129 indexed citations
14.
Gertz, Morie A., Robert M. Petitt, Jean Perrault, & Robert A. Kyle. (1987). Autosomal Dominant Familial Mediterranean Fever-Like Syndrome With Amyloidosis. Mayo Clinic Proceedings. 62(12). 1095–1100. 34 indexed citations
15.
Brimijoin, Stephen, P. Hammond, & Robert M. Petitt. (1986). Paroxysmal Nocturnal Hemoglobinuria: Erythrocyte Acetylcholinesterase Deficit Analyzed by Immunoassay and Fluorescence-Activated Sorting. Mayo Clinic Proceedings. 61(7). 522–529. 10 indexed citations
16.
Petitt, Robert M., et al.. (1986). Protein deficiency in premature infants receiving parenteral nutrition. American Journal of Clinical Nutrition. 44(5). 610–613. 7 indexed citations
17.
Solberg, Lawrence A., et al.. (1982). Treatment of thrombotic thrombocytopenic purpura with plasma exchange, antiplatelet agents, corticosteroid, and plasma infusion: Mayo clinic experience. Journal of Clinical Apheresis. 1(1). 6–13. 21 indexed citations
18.
Gertz, Morie A., Robert M. Petitt, Alvaro A. Pineda, Mark R. Wick, & Edwin A. Burgstaler. (1981). Vinblastine-Loaded Platelets for Autoimmune Hemolytic Anemia. Annals of Internal Medicine. 95(3). 325–326. 9 indexed citations
19.
Petitt, Robert M.. (1980). Thrombotic Thrombocytopenic Purpura: A Thirty Year Review. Seminars in Thrombosis and Hemostasis. 6(4). 350–355. 56 indexed citations
20.
Petitt, Robert M.. (1951). Vertebrate Remains in Barn Owl Pellets from Stanton County, Kansas. Transactions of the Kansas Academy of Science. 54(3). 395–395. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kip R. Hartman Breakdown of academic impact, for papers by Junji Tomiyama Breakdown of academic impact, for papers by C. H. W. Leeksma Breakdown of academic impact, for papers by R Goudsmit Breakdown of academic impact, for papers by Sonja Skoupy Breakdown of academic impact, for papers by C. Garner Breakdown of academic impact, for papers by Raïfah Makdassi Breakdown of academic impact, for papers by Y. Ravindranath Breakdown of academic impact, for papers by Z Rolović Breakdown of academic impact, for papers by Éstelle Desport
Rankless by CCL
2026